Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021 Post published:December 1, 2020 Post category:Press Release
Entheon Biomedical to Begin Trading on the Frankfurt Exchange Post published:November 26, 2020 Post category:Press Release
Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange Post published:November 12, 2020 Post category:Press Release
Entheon to List on CSE on or about Nov 12th Under Symbol ENBI Post published:November 6, 2020 Post category:Press Release
Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE Post published:October 28, 2020 Post category:Press Release
MPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp. and Financing Post published:July 3, 2020 Post category:Press Release